Other substances

[(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

[(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate on PubChem

Synonyms

ZINC3831201; ZINC03831201

 

Structure image - [(2S,3S,4S,5S)-5-Hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate

C1=CC(=CN=C1)C(=O)OC[C@H]2[C@@H]([C@@H]([C@@](O2)(COC(=O)C3=CN=CC=C3)O)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5

Supporting references

Link Tested on Impact factor Notes Publication date
A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor
3CLpro Small molecule In silico 		in silico 3.22

Predicted to bind the SARS-CoV-2 3C-like protease.

 Sep/17/2020
Export (.csv)